Lateral flow immunoassay (LFIA), as a core technology of point-of-care testing (POCT), holds significant value in clinical hormone detection, vitamin screening, pathogen diagnosis, and biomarker analysis. Notably, spherical nanomaterials, leveraging...
Zhang et al. (Thu,) studied this question.